<DOC>
	<DOC>NCT00532415</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of triamcinolone acetonide suspension when used for visualization of structures in the back of the eye during eye surgery.</brief_summary>
	<brief_title>Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy</brief_title>
	<detailed_description />
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Patients planning to undergo pars plana vitrectomy with good vision in the nonsurgery eye. Other protocoldefined inclusion criteria may apply. Patients under 18. Patients with previous vitrectomy, elevated intraocular pressure (IOP) and/or history of ocular inflammatory disease. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Vitrectomy</keyword>
	<keyword>Visualization</keyword>
</DOC>